Evidence map›Paper›PMID 42910162›Full record

ReviewTheranostics2026

Harnessing ultrasound-responsive technologies for precision periodontitis therapy: a perspective.

Chao Xing, Sibtain Muhammad, Bing Guo

Abstract readReview
In one paragraph

Review in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chao XingDepartment of Stomatology, The People's Hospital of Baoan Shenzhen, No. 118 Longjing Road, Baoan District, Shenzhen, Guangdong 518101, China.
Sibtain MuhammadSchool of Science, College of Frontier Sciences, Harbin Institute of Technology, Shenzhen, 518055, China.
Bing GuoSchool of Science, College of Frontier Sciences, Harbin Institute of Technology, Shenzhen, 518055, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontitis disease normally shows oxidative stress, immunological dysregulation, alteration of the periodontal bacterial ecology, and persistent alveolar bone loss. These mechanisms aggravate problems across the body in conjunction with causing tooth loss. The-state-of-the-art therapies using antimicrobial agents and mechanical debridement often fail to regulate immune signaling, clear infection, or repair tissue. Most recently, ultrasound-responsive materials have stood out to show advantages in restoring periodontal balance, which include two types (piezoelectric and sonodynamic materials). For sonodynamic materials, they generate reactive oxygen species (ROS) via acoustic cavitation, which degrades biofilms and disables microorganisms through oxidative damage. For piezoelectric materials, they convert mechanical stress into electrical polarization, resulting in surface charges that drive redox processes, affect immunological responses, and stimulate bone growth. Importantly, we highlight, to improve the periodontitis treatment outcomes, how these materials are incorporated into platforms such as injectable hydrogels, membranes, and scaffolds, which serve as carrier matrices for placing active medicines and improving spatiotemporal control. Also, we point out that integration of piezoelectric and sonodynamic technologies provides a way to combine antibacterial activity with regeneration stimuli. Moreover, challenges such as material stability, activation accuracy, and clinical translation are there and greater mechanistic understanding and rigorous design criteria are required for further development.

Indexed as

PeriodontitisPrecision MedicineUltrasonic TherapyAnimalsAnti-Bacterial AgentsBiofilmsHumansReactive Oxygen SpeciesAnti-Bacterial AgentsReactive Oxygen Speciesbacteriaperiodontitispiezoelectric dynamic therapysonodynamic therapyultrasound

Identifiers

PMID42910162
PMCPMC13685042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.